AU - Bubna, Aditya TI - Janus Kinase Inhibitors in Dermatology PT - REVI DP - 2019 Jan 1 TA - Indian Journal of Drugs in Dermatology PG - 6-13 VI - 5 IP - 1 4099- https://www.ijdd.in/article.asp?issn=2455-3972;year=2019;volume=5;issue=1;spage=6;epage=13;aulast=Bubna;type=0 4100- https://www.ijdd.in/article.asp?issn=2455-3972;year=2019;volume=5;issue=1;spage=6;epage=13;aulast=Bubna AB - Janus kinase (JAK) inhibitors are a new addition in the armamentarium of drugs in the treatment of autoimmune dermatoses. They have proven to be valuable in treating a variety of inflammatory dermatoses with lesser side effects compared to their biological counterparts. This review throws light on JAK inhibitors and their role in dermatologic diseases.